Variable number of tandem repeats of TNF receptor type 2 promoter as genetic biomarker of susceptibility to develop invasive pulmonary aspergillosis
Abstract
Tumor necrosis factor alpha (TNF-alpha) and lymphotoxin alpha (LT-alpha) are pivotal mediators of inflammatory responses in fungal infection diseases. We hypothesized that polymorphisms in genes of these cytokines or their receptors might increase the susceptibility of hematologic patients to develop invasive pulmonary aspergillosis (IPA). One hundred two hematologic patients and 124 age-matched controls were enrolled in the study, and the following standard single nucleotide polymorphisms were investigated: TNF-alpha -308 and +489, LT-alpha +252 and Tumor Necrosis Factor Receptor 2 (TNFR2) +676. Variable number of tandem repeats (VNTRs) at position -322 of the TNFR2 gene were also studied. Genotypic and allelic frequencies were similar between patients and controls. IPA was diagnosed in 54 of the 102 patients according to consensus criteria published by the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group. TNF-alpha and LT-alpha polymorphisms were not associated with presence of IPA. Susceptibility to IPA was strongly associated with VNTR at position -322 in the promoter region of the TNR2 gene (p = 0.029) but was not associated with the presence of TNFR2 +676 polymorphism. A genetic difference in TNFR2 promoter VNTR may play a major role in susceptibility to IPA infection.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Polymorphisms within the tumor necrosis factor-alpha gene and its receptors are associated with susceptibility to aspergillosis.
“Polymorphisms within the tumor necrosis factor-α (TNF-α) gene [32] and its receptors [37,38] have also been associated with susceptibility to aspergillosis.”
From Race and ethnicity: Risk factors for fungal infections? (2023) · cites this paper as [38]
Cites
Aşçıoğlu, S., Rex, J. H., de Pauw, B., Bennett, J. E., Billé, J., Crokaert, F., Denning, D. W., Donnelly, J. P., Edwards, J. E., Erjavec, Z., et al. (2002) · Clinical Infectious Diseases · doi:10.1086/323335 · Cited by 2,315 · see citing works
Wilson, A. G., Symons, J. A., McDowell, T. L., McDevitt, H. O., & Duff, G. W. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.7.3195 · Cited by 2,217 · see citing works
The Tumor Necrosis Factor Ligand and Receptor Families
Bazzoni, F., & Beutler, B. (1996) · New England Journal of Medicine · doi:10.1056/nejm199606273342607 · Cited by 1,208 · see citing works
Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria
McGuire, W. L., Hill, A. V. S., Allsopp, C. E. M., Greenwood, B. M., & Kwiatkowski, D. P. (1994) · Nature · doi:10.1038/371508a0 · Cited by 1,166 · see citing works
Ozaki, K., Ohnishi, Y., Iida, A., Sekine, A., Yamada, R., Tsunoda, T., Sato, H., Sato, H., Hori, M., Nakamura, Y., et al. (2002) · Nature Genetics · doi:10.1038/ng1047 · Cited by 940 · see citing works
Gerson, S. L., TALBOT, G. H., Hurwitz, S., STROM, B. L., LUSK, E. J., & Cassileth, P. A. (1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-100-3-345 · Cited by 761 · see citing works
TNF Receptor-Deficient Mice Reveal Divergent Roles for p55 and p75 in Several Models of Inflammation
Peschon, J. J., Torrance, D., Stocking, K. L., Glaccum, M. B., Otten, C., Willis, C. R., Charrier, K., Morrissey, P., Ware, C. B., & Mohler, K. M. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.2.943 · Cited by 706 · see citing works
Jacob, C. O., Fronek, Z., Lewis, G. D., Koo, M., Hansen, J. A., & McDevitt, H. O. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.3.1233 · Cited by 622 · see citing works
Schaffner, A., Douglas, H., & Braude, A. I. (1982) · Journal of Clinical Investigation · doi:10.1172/jci110489 · Cited by 618 · see citing works
Louis, E. J., Franchimont, D. P., Piron, A., Gevaert, Y., Schaaf‐Lafontaine, N., Roland, S., Mahieu, P. R., Malaise, M., Groote, D. D., Louis, R. E., et al. (1998) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.1998.00662.x · Cited by 575 · see citing works
Tartaglia, L. A., Pennica, D., & Goeddel, D. V. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)46661-0 · Cited by 570 · see citing works
Pociot, F., Briant, L., Jongeneel, C. V., Mølvig, J., Worsaae, H., Abbal, M., Thomsen, M., Nerup, J., & Cambon‐Thomsen, A. (1993) · European Journal of Immunology · doi:10.1002/eji.1830230135 · Cited by 549 · see citing works
Stuber, F. E., Petersen, M., Bokelmann, F., & Schade, U. F. (1996) · Critical Care Medicine · doi:10.1097/00003246-199603000-00004 · Cited by 549 · see citing works
Messer, G., Spengler, U., Jung, M., Honold, G., Blömer, K., Pape, G. R., Riethmüller, G., & Weiss, E. H. (1991) · The Journal of Experimental Medicine · doi:10.1084/jem.173.1.209 · Cited by 537 · see citing works
Invasive Aspergillosis in Transplant Recipients
Paterson, D. L., & Singh, N. (1999) · Medicine · doi:10.1097/00005792-199903000-00003 · Cited by 359 · see citing works
Marks, J. D., Marks, C. B., Ljuce, J. M., Montgomery, A. B., Turner, J., Metz, C. A., & Murray, J. F. (1990) · American Review of Respiratory Disease · doi:10.1164/ajrccm/141.1.94 · Cited by 329 · see citing works
Invasive Aspergillosis in Acute Leukemia: Correlation with Nose Cultures and Antibiotic Use
Aisner, J., MURILLO, J., SCHIMPFF, S. C., & Steere, A. C. (1979) · Annals of Internal Medicine · doi:10.7326/0003-4819-90-1-4 · Cited by 271 · see citing works
Role of TNF-alpha in pulmonary host defense in murine invasive aspergillosis.
Mehrad, B., Strieter, R. M., & Standiford, T. J. (1999) · PubMed · Cited by 264 · see citing works
Cytokine‐ and T Helper–Dependent Lung Mucosal Immunity in Mice with Invasive Pulmonary Aspergillosis
Cenci, E., Mencacci, A., d’Ostiani, C. F., Sero, G. D., Mosci, P., Montagnoli, C., Bacci, A., & Romani, L. R. (1998) · The Journal of Infectious Diseases · doi:10.1086/314493 · Cited by 253 · see citing works
PERUSSIA, B., Kobayashi, M., Rossi, M., Anegón, I., & Trinchieri, G. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.138.3.765 · Cited by 247 · see citing works
In Vivo Bronchoalveolar Macrophage Defense Against Rhizopus oryzae and Aspergillus fumigatus
Waldorf, A. R., Levitz, S. M., & Diamond, R. D. (1984) · The Journal of Infectious Diseases · doi:10.1093/infdis/150.5.752 · Cited by 247 · see citing works
Role of TNF-α in Pulmonary Host Defense in Murine Invasive Aspergillosis
Mehrad, B., Strieter, R. M., & Standiford, T. J. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.3.1633 · Cited by 244 · see citing works
Tumor necrosis factor mediates lung antibacterial host defense in murine Klebsiella pneumonia
Laichalk, L. L., Kunkel, S. L., Strieter, R. M., Danforth, J. M., Bailie, M. B., & Standiford, T. J. (1996) · Infection and Immunity · doi:10.1128/iai.64.12.5211-5218.1996 · Cited by 218 · see citing works
Receptor Binding and Activation of Polymorphonuclear Neutrophils by Tumor Necrosis Factor-Alpha
Shalaby, M. R., Palladino, M. A., Hirabayashi, S. E., Eessalu, T. E., Lewis, G. D., Shepard, H. M., & Aggarwal, B. B. (1987) · Journal of Leukocyte Biology · doi:10.1002/jlb.41.3.196 · Cited by 216 · see citing works
Th1 and Th2 cytokines in mice with invasive aspergillosis
Cenci, E., Perito, S., Enssle, K.-H., Mosci, P., Latgé, J., Romani, L. R., & Bistoni, F. (1997) · Infection and Immunity · doi:10.1128/iai.65.2.564-570.1997 · Cited by 216 · see citing works
Emerging and less common fungal pathogens
Fleming, R. V., Walsh, T. J., & Anaissie, E. J. (2002) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(02)00041-7 · Cited by 215 · see citing works
Recent trends in the epidemiology of invasive mycoses
Clark, T. A., & Hajjeh, R. A. (2002) · Current Opinion in Infectious Diseases · doi:10.1097/00001432-200212000-00003 · Cited by 210 · see citing works
Levitz, S. M., Selsted, M. E., Ganz, T., Lehrer, R. I., & Diamond, R. D. (1986) · The Journal of Infectious Diseases · doi:10.1093/infdis/154.3.483 · Cited by 195 · see citing works
Ferrante, A., Nandoskar, M., Walz, A., et al. (2009) · International Archives of Allergy and Applied Immunology · doi:10.1159/000234610 · Cited by 174 · see citing works
Gosselin, D. R., DeSanctis, J., Boulé, M., Skamene, E., Matouk, C. C., & Radzioch, D. (1995) · Infection and Immunity · doi:10.1128/iai.63.9.3272-3278.1995 · Cited by 154 · see citing works
Roilides, E., Dimitriadou‐Georgiadou, A., Sein, T., Kadiltsoglou, I., & Walsh, T. J. (1998) · Infection and Immunity · doi:10.1128/iai.66.12.5999-6003.1998 · Cited by 153 · see citing works
Genetics of tumour necrosis factor-alpha in autoimmune, infectious, and neoplastic diseases.
Wilson, A. G., di Giovine, F. S., & Duff, G. W. (1995) · PubMed · Cited by 151 · see citing works
Netea, M. G., van Tits, L. J. H., Curfs, J. H. A. J., Amiot, F., Meis, J. F. G. M., van der Meer, J. W. M., & Kullberg, B. J. (1999) · PubMed · Cited by 147 · see citing works
Corticosteroid treatment as a risk factor for invasive aspergillosis in patients with lung disease.
Palmer, L. B., Greenberg, H. E., & Schiff, M. J. (1991) · Thorax · doi:10.1136/thx.46.1.15 · Cited by 145 · see citing works
Tumor necrosis factor alpha in the pathogenesis of cerebral malaria.
Gimenez, F., de Lagerie, S. B., Fernandez, C., Pino, P., & Mazier, D. (2003) · PubMed Central · doi:10.1007/s00018-003-2347-x · Cited by 135 · see citing works
Weinberger, M., Elattar, I. A., Marshall, D., Steinberg, S. M., Redner, R. L., Young, N. S., & Pizzo, P. A. (1992) · Medicine · doi:10.1097/00005792-199201000-00003 · Cited by 132 · see citing works
Komata, T., Tsuchiya, N., Matsushita, M., Hagiwara, K., & Tokunaga, K. (1999) · Tissue Antigens · doi:10.1034/j.1399-0039.1999.530602.x · Cited by 123 · see citing works
O’Keefe, G. E., Hybki, D. P., & Munford, R. S. (2002) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/00005373-200205000-00001 · Cited by 121 · see citing works
Gruss, H. J. (1996) · International Journal of Clinical & Laboratory Research · doi:10.1007/bf02592977 · Cited by 121 · see citing works
Netea, M. G., van Tits, L. J. H., Curfs, J. H. A. J., Amiot, F., Meis, J. F. G. M., van der Meer, J. W. M., & Kullberg, B. J. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.3.1498 · Cited by 118 · see citing works
Saugier-Véber, P., Devergié, A., Sulahian, A., et al. (1993) · PubMed · Cited by 112 · see citing works
Fungal infections after bone marrow transplant
Wingard, J. R. (1999) · Transplantation and Cellular Therapy · doi:10.1053/bbmt.1999.v5.pm10371357 · Cited by 109 · see citing works
Cytokine Networking in Lungs of Immunocompetent Mice in Response to Inhaled Aspergillus fumigatus
Brieland, J. K., Jackson, C. A., Menzel, F., Loebenberg, D., Cacciapuoti, A. F., Halpern, J., Hurst, S. D., Muchamuel, T., Debets, R., KASTELEIN, R. A., et al. (2001) · Infection and Immunity · doi:10.1128/iai.69.3.1554-1560.2001 · Cited by 104 · see citing works
Diamond, R. D., Lyman, C. A., & Wysong, D. R. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115050 · Cited by 97 · see citing works
Ullmann, A. J. (2003) · Current Medical Research and Opinion · doi:10.1185/030079903125001884 · Cited by 84 · see citing works
Dofferhoff, A. S. M., Esselink, M., de Vries-Hospers, H. G., et al. (1993) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/31.3.373 · Cited by 78 · see citing works
de la Mata, M., Meager, A., Rolando, N., Daniels, H. M., Nouri‐Aria, K. T., Goka, A. K. J., Eddleston, A. L. W. F., Alexander, G., & Williams, R. L. (1990) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1990.tb05475.x · Cited by 75 · see citing works
Steinshamn, S., Bemelmans, M. H. A., van Tits, L. J., et al. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.5.2155 · Cited by 73 · see citing works
Phagocyte function and cytokine production in community acquired pneumonia.
Moussa, K., Michie, H. J., Cree, I. A., et al. (1994) · Thorax · doi:10.1136/thx.49.2.107 · Cited by 72 · see citing works
Netea, M. G., Blok, W. L., Kullberg, B. J., et al. (1995) · The Journal of Infectious Diseases · doi:10.1093/infdis/171.2.393 · Cited by 69 · see citing works
Tumor necrosis factor receptor II (TNFRII) exon 6 polymorphism in systemic lupus erythematosus
Al-Ansari, A., Ollier, W., Villarreal, J. S. C., et al. (2000) · Tissue Antigens · doi:10.1034/j.1399-0039.2000.550122.x · Cited by 68 · see citing works
TNF and LTA gene polymorphisms reveal different risk in gastric and duodenal ulcer patients
Lanas, Á., García-González, M. A., Santolaria, S., et al. (2001) · Genes and Immunity · doi:10.1038/sj.gene.6363798 · Cited by 64 · see citing works
Taramelli, D., Malabarba, M. G., Sala, G., Basilico, N., & Cocuzza, G. (1996) · Medical Mycology · doi:10.1080/02681219680000081 · Cited by 62 · see citing works
Cytokines in host defense againstAspergillus: recent advances
Phadke, A. P., & Mehrad, B. (2005) · Medical Mycology · doi:10.1080/13693780500052099 · Cited by 57 · see citing works
de Jong, B. A., Westendorp, R. G. J., Bakker, A. M., & Huizinga, T. W. J. (2002) · Genes and Immunity · doi:10.1038/sj.gene.6363824 · Cited by 51 · see citing works
Clinical efficacy of echinocandin antifungals
Arathoon, E. (2001) · Current Opinion in Infectious Diseases · doi:10.1097/00001432-200112000-00004 · Cited by 51 · see citing works
Induction of Tumor Necrosis Factor- in Murine Candida albicans Infection
Allendoerfer, R., Magee, D. M., Smith, J. G., Bonewald, L. F., & Graybill, J. R. (1993) · The Journal of Infectious Diseases · doi:10.1093/infdis/167.5.1168 · Cited by 47 · see citing works
Cytokine- and T-helper-dependent immunity in murine aspergillosis
Cenci, E., Mencacci, A., Fèd'Ostiani, C., Montagnoli, C., Bacci, A., Sero, G. D., Perito, S., Bistoni, F., & Romani, L. R. (1998) · Research in Immunology · doi:10.1016/s0923-2494(98)80768-2 · Cited by 42 · see citing works
Vonk, A. G., Netea, M. G., van Krieken, J. H., van der Meer, J. W. M., & Kullberg, B. J. (2002) · The Journal of Infectious Diseases · doi:10.1086/345818 · Cited by 29 · see citing works
Genome scan analyses and positional cloning strategy in IBD: successes and limitations
Wild, G., & Rioux, J. D. (2004) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2003.12.007 · Cited by 22 · see citing works
A bi-allelic VNTR in the human TNFR2 (p75) gene promoter
Keen, L. J., Wood, N., Olomolaiye, O. O., et al. (1999) · Genes and Immunity · doi:10.1038/sj.gene.6363644 · Cited by 13 · see citing works
Warrington (2001) · Pure Amsterdam UMC · doi:10.1002/1529-0131(200101)44:1 · Cited by 2 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Romani, L. (2011) · Nature Reviews Immunology · doi:10.1038/nri2939 · Cited by 1,793 · see citing works
Toll-like receptor 4 polymorphisms and aspergillosis in stem-cell transplantation
Bochud, P.-Y., Chien, J. W., Marr, K. A., Leisenring, W. M., Upton, A., Janer, M., Rodrigues, S. D., Li, S., Hansen, J. A., Zhao, L. P., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802629 · Cited by 453 · see citing works
Invasive Aspergillosis: Epidemiology, Diagnosis and Management in Immunocompromised Patients
Maschmeyer, G., Haas, A., & Cornely, O. A. (2007) · Drugs · doi:10.2165/00003495-200767110-00004 · Cited by 366 · see citing works
Breakthrough invasive fungal infections: Who is at risk?
Jenks, J. D., Cornely, O. A., Chen, S. C. ‐., Thompson, G. R., & Hoenigl, M. (2020) · Mycoses · doi:10.1111/myc.13148 · Cited by 191 · see citing works
Sainz, J., Pérez, E., Gómez-Lopera, S., & Jurado, M. (2008) · Journal of Clinical Immunology · doi:10.1007/s10875-008-9197-0 · Cited by 84 · see citing works
Self-citationSainz, J., Salas-Alvarado, I., López-Fernández, E., Olmedo, C., Comino, A., García, F., Blanco, A., Gómez-Lopera, S., Oyonarte, S., Bueno, P., et al. (2010) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463201002300205 · Cited by 56 · see citing works
Self-citationRace and ethnicity: Risk factors for fungal infections?
Jenks, J. D., Aneke, C. I., Al-Obaidi, M. M., Egger, M., Garcia, L., Gaines, T., Hoenigl, M., & Thompson, G. R. (2023) · PLOS Pathogens · doi:10.1371/journal.ppat.1011025 · Cited by 55 · see citing works
Lupiañez, C. B., Canet, L. M., Carvalho, A., Alcazar-Fuoli, L., Springer, J., Lackner, M., Segura-Catena, J., Comino, A., Olmedo, C., Ríos, R., et al. (2016) · Infection and Immunity · doi:10.1128/iai.01359-15 · Cited by 42 · see citing works
Self-citationImmunomodulation as a Therapy for Aspergillus Infection: Current Status and Future Perspectives
Lauruschkat, C. D., Einsele, H., & Loeffler, J. (2018) · Journal of Fungi · doi:10.3390/jof4040137 · Cited by 32 · see citing works
- Authors
- Sainz, J., Pérez, E., Hassan, L., Moratalla, A., Romero, A., Collado, M. D., & Jurado, M.
- Affiliations
- Hospital Universitario Virgen de las Nieves (ES)
- ORCID
- Jurado, Manuel
- Venue
- Human Immunology
- Publisher
- Elsevier BV
- Published
- 2007-01
- Volume
- 68
- Issue
- 1
- Pages
- 41-50
- ISSN
- 0198-8859 (ISSN-L)
- OpenAlex
- W2053563213
- Cited by
- 81
- References
- 62
- Citations by year
- 2024: 2 · 2023: 2 · 2022: 2 · 2021: 5 · 2020: 5 · 2019: 3 · 2018: 2 · 2017: 3 · 2016: 6 · 2015: 5 · 2014: 4 · 2013: 2 · 2012: 4
- FWCI
- 3.49
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Human Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Servicio Andaluz de Salud (1/02/06)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Immunology and Microbiology › Immunology › Immunodeficiency and Autoimmune Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Keywords
- invasive pulmonary aspergillosis, variable number tandem repeats, promoter polymorphism, genetic susceptibility, hematologic patients, TNF-α, lymphotoxin, single nucleotide polymorphisms, fungal infection susceptibility, genetic biomarkers
- MeSH terms
- Aspergillosis, Female, Genetic Markers, Humans, Lung Diseases, Fungal, Male, Middle Aged, Promoter Regions, Genetic, Prospective Studies, Minisatellite Repeats, Genetic Predisposition to Disease, Receptors, Tumor Necrosis Factor, Type II
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review